Key result
Drug-eluting coronary stents may be associated with a small increased risk of late stent thrombosis compared with bare-metal stents.
Why the study?
Do drug-eluting coronary stents increase the risk of late stent thrombosis compared to bare-metal stents?
Comparison
Drug-eluting coronary stents vs Bare-metal stents
Design
Editorial
Authors
Loading...
This editorial introduces a series of articles addressing the potential increased risk of late stent thrombosis associated with drug-eluting stents compared to bare-metal stents.
Do drug-eluting coronary stents increase the risk of late stent thrombosis compared to bare-metal stents?
This editorial introduces a series of articles addressing the potential increased risk of late stent thrombosis associated with drug-eluting stents compared to bare-metal stents.
Curfman et al. (2007) conducted an editorial in Late stent thrombosis. Drug-eluting coronary stents vs. Bare-metal stents was evaluated on Late stent thrombosis. Drug-eluting coronary stents may be associated with a small increased risk of late stent thrombosis compared with bare-metal stents.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: